Literature DB >> 1991314

Hereditary ovarian cancer. Heterogeneity in age at diagnosis.

H T Lynch1, P Watson, C Bewtra, T A Conway, C R Hippee, P Kaur, J F Lynch, B A Ponder.   

Abstract

An unknown fraction of the ovarian cancer burden occurs in women with a family history indicative of a putative autosomal dominantly inherited cancer susceptibility syndrome. The results from a five-generation, extended, hereditary breast-ovarian cancer kindred are described 10 years after it was initially ascertained. Significantly more cancers were observed in high-risk family members during this decade than were expected (P less than 0.001). The age of ovarian cancer diagnosis was studied in additional ovarian cancer-prone families of three types: site-specific ovarian cancer syndrome, the breast-ovarian cancer syndrome, and Lynch syndrome II. The age of onset in each of the three sets was significantly (P less than 0.001) earlier than the general population mean of 59, and there were significant differences in the age of onset (P = 0.050) among these three cohorts. Ovarian cancer histology was similar to that of patients with negative family histories. There may be clinically significant heterogeneity in the age at diagnosis of ovarian cancer among these ovarian cancer-prone syndromes. This has important implications for understanding its natural history and targeting surveillance-management strategies.

Entities:  

Mesh:

Year:  1991        PMID: 1991314     DOI: 10.1002/1097-0142(19910301)67:5<1460::aid-cncr2820670534>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  Forth nightly review: hereditary ovarian carcinoma.

Authors:  L Kasprzak; W D Foulkes; A N Shelling
Journal:  BMJ       Date:  1999-03-20

2.  Age at diagnosis and multiple primary cancers of the breast and ovary.

Authors:  P J Suris-Swartz; J M Schildkraut; M F Vine; I Hertz-Picciotto
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Genetic predisposition to ovarian cancer.

Authors:  J L Freddo
Journal:  West J Med       Date:  1992-06

Review 4.  Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.

Authors:  Murray Joseph Casey; Agnes B Colanta
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

5.  Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

Authors:  T H Bourne; S Campbell; K M Reynolds; M I Whitehead; J Hampson; P Royston; T J Crayford; W P Collins
Journal:  BMJ       Date:  1993-04-17

Review 6.  Clinical management of women at increased risk for breast cancer.

Authors:  V G Vogel; A Yeomans; E Higginbotham
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

7.  Linkage studies with 17q and 18q markers in a breast/ovarian cancer family.

Authors:  B J Milner; L A Allan; K F Kelly; D Cruickshank; M Hall; A Johnston; H Kitchener; D Parkin; N Haites
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  Malignant tumours of the genital tract among Batswana women.

Authors:  M N Tanko; M A Kayembe; F Cainelli; S Vento
Journal:  Ghana Med J       Date:  2012-09

9.  Familial cluster of ovarian small cell carcinoma: a new mendelian entity?

Authors:  M Longy; C Toulouse; P Mage; J Chauvergne; M Trojani
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

10.  A qualitative assessment of an online support community for ovarian cancer patients.

Authors:  Preetinder Singh Gill; Billy Whisnant
Journal:  Patient Relat Outcome Meas       Date:  2012-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.